Expression of CCL2 has also been found to be decreased in prostate adenocarcinoma compared to benign prostate hyperplasia (Mazzucchelli et al, 1996) and cervical carcinomas compared to normal or hyperplastic squamous epithelium (Riethdorf et al, 1998; Kleine-Lowinski et al, 1999). This evidence concerns the gene CCL2 and cervical carcinoma.